Oesophageal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with squamous cell carcinoma (a specific type of cancer) of the esophagus (food pipe), confirmed by a tissue test
- People whose esophageal tumor is located in the chest area
- People whose cancer is at a specific stage before treatment — broadly meaning the tumor is locally advanced but has not spread to distant parts of the body (confirm with trial site for exact staging details)
- People aged between 18 and 75 years old
- People who are generally able to carry out daily activities with little or no restriction, as measured by a standard medical scale (ECOG score of 0 or 1)
- People whose heart is functioning adequately, based on an ECG test — and, where relevant, an additional heart scan showing the heart pumping at least 50% efficiency
- People whose lungs are functioning adequately, based on breathing tests meeting specific minimum levels (confirm with trial site for exact values)
- People whose bone marrow is producing enough blood cells, based on blood test results meeting specific minimum levels
- People whose liver is functioning adequately, based on blood test results within acceptable ranges
- People whose kidneys are functioning adequately, based on blood test results within acceptable ranges
- People who have given written consent and are willing and able to follow the study requirements
Who may not be able to join:
- People whose esophageal cancer is not the squamous cell carcinoma type
- People whose cancer is at an advanced stage that cannot be surgically removed, or has spread to other parts of the body
- People whose cancer is at an early stage (before treatment stage cT1–2N0–1M0) (confirm with trial site)
- People whose cancer has spread to several nearby lymph nodes, or whose tumor has grown into surrounding structures in a way that cannot be surgically removed
- People who have, or have previously had, another cancer that may interfere with treatment or assessment in the opinion of the treating doctor
- People with significant health conditions that make it unlikely they could tolerate the treatments — for example, serious heart disease, a heart attack within the past 12 months, significant lung disease, or significant problems with bone marrow, liver, or kidney function
- Women who are pregnant, breastfeeding, or capable of becoming pregnant and not willing to use contraception during the trial
- People with an allergy to any of the drugs used in the trial
- People who are currently taking part in, or have taken part in within the last 30 days, another clinical trial involving a treatment that could interfere with this study
- People who are considered unlikely to be able to follow the study requirements
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Di Ge, MD, Fudan University
Phone: +86 13611972978
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Major pathological regression (MPR) rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.